Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors.

Bumroongkit K, Rannala B, Traisathit P, Srikummool M, Wongchai Y, Kangwanpong D.

Cancer Genet Cytogenet. 2008 Aug;185(1):20-7. doi: 10.1016/j.cancergencyto.2008.04.009.

PMID:
18656689
2.

TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.

de Anta JM, Jassem E, Rosell R, Martínez-Roca M, Jassem J, Martínez-López E, Monzó M, Sánchez-Hernández JJ, Moreno I, Sánchez-Céspedes M.

Oncogene. 1997 Dec 11;15(24):2951-8.

3.

BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.

Eachkoti R, Hussain I, Afroze D, Aejazaziz S, Jan M, Shah ZA, Das BC, Siddiqi MA.

Cancer Lett. 2007 Apr 18;248(2):308-20. Epub 2006 Sep 22.

PMID:
16996204
4.

Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.

Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.

Lung Cancer. 2006 Apr;52(1):9-14. Epub 2006 Feb 24.

PMID:
16499995
5.

Types and localisation of p53 gene mutations: a report on 332 non-small cell lung cancer patients.

Jassem E, Nikliński J, Rosell R, Niklińska W, Jakóbkiewicz J, Monzo M, Chyczewski L, Kobierska G, Skokowski J, Zylicz M, Jassem J.

Lung Cancer. 2001 Dec;34 Suppl 2:S47-51.

PMID:
11720741
6.

High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.

Chang MY, Chong IW, Chen FM, Wang JY, Cheng TL, Cheng YJ, Sheu CC, Hung SY, Yang MC, Lin SR.

Cancer Lett. 2005 May 26;222(2):195-204. Epub 2004 Dec 23.

PMID:
15863268
7.

TP53 mutation, allelism and survival in non-small cell lung cancer.

Nelson HH, Wilkojmen M, Marsit CJ, Kelsey KT.

Carcinogenesis. 2005 Oct;26(10):1770-3. Epub 2005 May 19.

PMID:
15905205
8.

Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.

Lind H, Ekstrøm PO, Ryberg D, Skaug V, Andreassen T, Stangeland L, Haugen A, Zienolddiny S.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2077-81.

9.

Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients.

Gao W, Mady HH, Melhem MF, Keohavong P.

Mol Carcinog. 2009 Jul;48(7):633-41. doi: 10.1002/mc.20505.

PMID:
19072763
10.

[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].

Szymanowska A, Jassem E, Dziadziuszko R, Skrzypski M, Kobierska-Gulida G, Holm K, Borg A, Rzyman W, Limon J, Jassem J.

Pneumonol Alergol Pol. 2005;73(3):264-9. Polish.

PMID:
16989164
11.

Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN.

Regina S, Valentin JB, Lachot S, Lemarié E, Rollin J, Gruel Y.

Clin Chem. 2009 Oct;55(10):1834-42. doi: 10.1373/clinchem.2009.123695. Epub 2009 Aug 6.

12.

Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.

Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D.

Cancer Res. 2000 Jun 15;60(12):3155-9.

13.

TP53 mutations in Korean patients with non-small cell lung cancer.

Lee EB, Jin G, Lee SY, Park JY, Kim MJ, Choi JE, Jeon HS, Cha SI, Cho S, Kim CH, Park TI, Jung TH, Son JW, Park JY.

J Korean Med Sci. 2010 May;25(5):698-705. doi: 10.3346/jkms.2010.25.5.698. Epub 2010 Apr 16.

14.

Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer.

Cho S, Kim MJ, Choi YY, Yoo SS, Lee WK, Lee EJ, Jang EJ, Bae EY, Jin G, Jeon HS, Lee SY, Cha SI, Park TI, Kim CH, Park JY.

Lung Cancer. 2011 Jul;73(1):25-31. doi: 10.1016/j.lungcan.2010.10.023. Epub 2010 Dec 3.

PMID:
21129811
15.

Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract.

Law JC, Whiteside TL, Gollin SM, Weissfeld J, El-Ashmawy L, Srivastava S, Landreneau RJ, Johnson JT, Ferrell RE.

Clin Cancer Res. 1995 Jul;1(7):763-8.

16.

p53 intron 2 genotypes detected in normal specimens and lung carcinomas in Hong Kong.

Ge H, Wong MP, Lam WK, Lee J, Fu KH, Yew WW, Lung ML.

Oncol Rep. 1998 Sep-Oct;5(5):1265-7.

PMID:
9683848
17.

p53 gene mutations in non-small cell lung cancer from Thai patients.

Petmitr S, Makthiengtrong S, Sutinont P, Migasena P.

J Med Assoc Thai. 1999 Mar;82(3):250-5.

PMID:
10410479
18.

K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.

Yao R, Wang Y, D'Agostini F, Izzotti A, Lubet RA, You M, De Flora S.

Exp Lung Res. 2005 Mar;31(2):271-81.

PMID:
15824025
19.

Association study of TP53 polymorphisms with lung cancer in a Korean population.

Jung HY, Whang YM, Sung JS, Shin HD, Park BL, Kim JS, Shin SW, Seo HY, Seo JH, Kim YH.

J Hum Genet. 2008;53(6):508-14. doi: 10.1007/s10038-008-0278-y. Epub 2008 Mar 25.

PMID:
18363031
20.

Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.

Sepehr A, Tanière P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M, Etemad-Moghadam G, Kamangar F, Saidi F, Hainaut P.

Oncogene. 2001 Nov 1;20(50):7368-74. Erratum in: Oncogene 2002 Feb 28;21(10):1632.

Supplemental Content

Support Center